Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alnylam Pharmaceuticals

305.92
+2.150.71%
Volume:355.11K
Turnover:108.72M
Market Cap:39.89B
PE:-145.80
High:308.93
Open:303.22
Low:302.34
Close:303.77
Loading ...

US appeals court sides with Moderna on COVID patent claims

Reuters
·
Yesterday

RBC Capital Sticks to Its Buy Rating for Alnylam Pharma (ALNY)

TIPRANKS
·
30 May

TransCode Therapeutics Appoints Dr. Phillip D. Zamore to Scientific Advisory Board to Drive RNA Oncology Advancements

Reuters
·
28 May

Alnylam Pharmaceuticals to Present at Goldman Sachs 46th Annual Global Healthcare Conference

Reuters
·
28 May

Alnylam Pharma (ALNY) Receives a Buy from Barclays

TIPRANKS
·
27 May

Alnylam Pharmaceuticals Releases 2024 ESG Report Highlighting Environmental Impact and Health Equity Initiatives

Reuters
·
20 May

TD Cowen Reaffirms Their Buy Rating on Alnylam Pharma (ALNY)

TIPRANKS
·
19 May

U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, UnitedHealth, Wells Fargo

Reuters
·
15 May

Arbutus Biopharma Q1 2025: Revenue Up 20% to $1.8M, Net Loss Widens to $24.5M, EPS at $(0.13)

Reuters
·
14 May

Alnylam Pharmaceuticals Inc. Conducted Annual Meeting of Stockholders

Reuters
·
14 May

Evercore ISI Keeps Their Buy Rating on Alnylam Pharma (ALNY)

TIPRANKS
·
07 May

Alnylam to Webcast Presentation at BofA Securities 2025 Health Care Conference

Business Wire
·
05 May

Analyst Estimates: Here's What Brokers Think Of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) After Its First-Quarter Report

Simply Wall St.
·
04 May

Alnylam Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations

Simply Wall St.
·
03 May

Alnylam Delivers Q1 Surprise, Analysts Highlight Amvuttra Momentum, Limited Tariff Risk

Benzinga
·
03 May

Alnylam Q1 Earnings Beat Estimates, Product Revenues Rise Y/Y

Zacks
·
02 May

UBS Adjusts Alnylam Pharmaceuticals Price Target to $349 From $331, Maintains Buy Rating

MT Newswires Live
·
02 May

Analysts Have Conflicting Sentiments on These Healthcare Companies: American Well (AMWL), Alnylam Pharma (ALNY) and Teleflex (TFX)

TIPRANKS
·
02 May

Alnylam Pharmaceuticals Is Maintained at Buy by Chardan Capital

Dow Jones
·
02 May

Piper Sandler Sticks to Its Buy Rating for Alnylam Pharma (ALNY)

TIPRANKS
·
02 May